News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Haas Jason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2023 |
4
| Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 49,750 options to buy
@ $6.73, valued at
$334.8k
Granted 37,750 restricted stock units
@ $0 |
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/17/2022 |
4
| Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.59, valued at
$198.8k
Granted 80,000 restricted stock units
@ $0 |
|
| 10/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|